Literature DB >> 24048489

Peripheral administration of nesfatin-1 increases blood pressure in mice.

Aya Osaki1, Hiroyuki Shimizu2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048489     DOI: 10.1038/hr.2013.122

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  12 in total

1.  Increased blood pressure in nesfatin/nuclebindin-2-transgenic mice.

Authors:  Yusaku Mori; Hiroyuki Shimizu; Hideki Kushima; Munenori Hiromura; Michishige Terasaki; Michitaka Tanaka; Aya Osaki; Tsutomu Hirano
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

2.  Norepinephrine released by intestinal Paneth cells exacerbates ischemic AKI.

Authors:  Sang Jun Han; Mihwa Kim; Vivette Denise D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

3.  Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome.

Authors:  Peng Shen; Yingying Han; Bo Cai; Yu Wang
Journal:  Sleep Breath       Date:  2014-07-24       Impact factor: 2.816

Review 4.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

Review 5.  Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension.

Authors:  Christopher L Souders; Jasenka Zubcevic; Christopher J Martyniuk
Journal:  Cell Mol Neurobiol       Date:  2021-02-16       Impact factor: 5.046

6.  Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and visceral adiposity in fructose-fed hypertensive rats.

Authors:  Chu-Lin Chou; Cheng-Yoong Pang; Tony J F Lee; Te-Chao Fang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

7.  Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.

Authors:  Maryam N Alotibi; Amina M Alnoury; Amani M Alhozali
Journal:  Saudi Med J       Date:  2019-01       Impact factor: 1.484

8.  Nesfatin-1 suppresses peripheral arterial remodeling without elevating blood pressure in mice.

Authors:  Yusaku Mori; Hiroyuki Shimizu; Hideki Kushima; Tomomi Saito; Munenori Hiromura; Michishige Terasaki; Masakazu Koshibu; Hirokazu Ohtaki; Tsutomu Hirano
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

9.  Can Nesfatin-1 Predict Hypertension in Obese Children?

Authors:  Hatice Güneş; Filiz Alkan Baylan; Hakan Güneş; Fatih Temiz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-07-24

Review 10.  Current Understanding of the Role of Nesfatin-1.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  J Endocr Soc       Date:  2018-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.